Why the courts and the NDRC disagree over price fixing

As the NDRC becomes more aggressive in its price fixing enforcement, businesses in China are waiting for an appeal decision in a case where a Shanghai court has taken a different approach to the Commission's

4 minute readFebruary 22, 2013 at 02:35 AM

clpstaff

& clp articles

An appeal of the high-profile case involving Rainbow Medical and Johnson & Johnsonis now pending before the Shanghai Higher People's Court.

During the first instance at the Shanghai Intermediate People's Court, the judge ruled against Rainbow for failing to meet the burden of proof that the agreement between J&J and Rainbow had restricted

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)